Description

Fedbank Financial Services Limited has listed new Commercial Paper worth Rs. 100 crore on BSE Debt segment with effect from December 5, 2025.

Summary

Fedbank Financial Services Limited has listed new Commercial Paper issued on private placement basis on the BSE Debt segment effective December 5, 2025. The listing consists of 2,000 units of Commercial Paper with a face value of Rs. 5,00,000 each, totaling Rs. 100 crore. The instrument carries credit ratings of CRISIL A1+ and ICRA A1+.

Key Points

  • Securities: Commercial Paper issued on private placement basis
  • Quantity: 2,000 units of Rs. 5,00,000 each
  • Total Issue Size: Rs. 100 crore
  • Scrip Code: 730705
  • Scrip ID: FFSL041225
  • ISIN Number: INE007N14EM0
  • Credit Rating: CRISIL A1+, ICRA A1+
  • Face Value: Rs. 5,00,000
  • Issue Price: Rs. 4,91,688.50
  • Market Lot: 1
  • Trading denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Trading mode: Dematerialized form only
  • Issuing and Paying Agent: Federal Bank Limited

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE007N14EM0
  • Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
  • The tick size for the securities is 1 paise

Important Dates

  • Notice Date: December 5, 2025
  • Listing Date: December 5, 2025
  • Date of Allotment: December 4, 2025
  • Date of Redemption: March 5, 2026

Impact Assessment

This is a routine debt instrument listing with minimal market impact. The commercial paper is a short-term instrument (91 days tenor) issued on private placement basis. The high credit ratings (A1+ from both CRISIL and ICRA) indicate strong creditworthiness. The listing provides additional short-term debt investment options for institutional investors in the BSE Debt segment but does not affect broader market operations or regulatory framework.

Impact Justification

Routine listing of commercial paper on private placement basis with no regulatory changes or market-wide impact